{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T22:16:45Z","timestamp":1725661005419},"publisher-location":"Berlin, Heidelberg","reference-count":14,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642276965"},{"type":"electronic","value":"9783642276972"}],"license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-3-642-27697-2_11","type":"book-chapter","created":{"date-parts":[[2012,2,17]],"date-time":"2012-02-17T14:33:45Z","timestamp":1329489225000},"page":"145-157","source":"Crossref","is-referenced-by-count":5,"title":["Patterns of Clinical Trial Eligibility Criteria"],"prefix":"10.1007","author":[{"given":"Krystyna","family":"Milian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"ten Teije","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca","family":"Bucur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"van Harmelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"11_CR1","unstructured":"Trialx (June 2010), \n                    \n                      http:\/\/trialx.com\/"},{"key":"11_CR2","unstructured":"Clinicaltrials (2011), \n                    \n                      http:\/\/clinicaltrials.gov\/"},{"key":"11_CR3","unstructured":"Neo altto (neoadjuvant lapatinib and\/or trastuzumab treatment optimisation) study (2011), \n                    \n                      http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00553358"},{"key":"11_CR4","unstructured":"Topoisomerase ii alpha gene amplification and protein overexpression predicting efficacy of epirubicin (top) (2011), \n                    \n                      http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00162812"},{"key":"11_CR5","unstructured":"Aronson, A.R.: Metamap: Mapping text to the umls metathesaurus. In: Proceedings AMIA Symposium (2001)"},{"key":"11_CR6","unstructured":"Cunningham, H., Maynard, D., Bontcheva, K., Tablan, V.: GATE: A framework and graphical development environment for robust NLP tools and applications. In: Proceedings of the 40th Anniversary Meeting of the Association for Computational Linguistics (2002)"},{"issue":"4","key":"11_CR7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ijmedinf.2011.01.014","volume":"80","author":"S. Medlock","year":"2011","unstructured":"Medlock, S., Opondo, D., Eslami, S., Askari, M., Wierenga, P., de Rooij, S.E., Abu-Hanna, A.: Lerm (logical elements rule method): A method for assessing and formalizing clinical rules for decision support. International Journal of Medical Informatics\u00a080(4), 286\u2013295 (2011)","journal-title":"International Journal of Medical Informatics"},{"key":"11_CR8","unstructured":"Ohno-Machado, L., Wang, S., Mar, P., Boxwala, A.: Decision support for clinical trial eligibility determination in breast cancer. In: Proceedings AMIA Symposium (1999)"},{"key":"11_CR9","unstructured":"Ross, J., Tu, S.W., Carini, S., Sim, I.: Analysis of eligibility criteria complexity in clinical trials. In: AMIA Summits on Translational Science Proceedings (2010)"},{"key":"11_CR10","unstructured":"Sordo, M., Ogunyemi, O., Boxwala, A.A., Greenes, R.A.: Software specifications for gello: An object-oriented query and expression language for clinical decision support. Technical report, Decision Systems Group, Brigham & Women\u2019s Hospital, Harvard Medical School, Boston, MA (2003)"},{"key":"11_CR11","unstructured":"Tu, S., Peleg, M., Carini, S., Rubin, D., Sim, I.: Ergo: A templatebased expression language for encoding eligibility criteria. Technical report (2009)"},{"key":"11_CR12","doi-asserted-by":"crossref","unstructured":"Tu, S.W., Kemper, C.A., Lane, N.M., Carlson, R.W., Musen, M.A.: A methodology for determining patients eligibility for clinical trials. Methods of Information in Medicine (1993)","DOI":"10.1055\/s-0038-1634933"},{"key":"11_CR13","unstructured":"Wang, S., Ohno-Machado, L., Mar, P., Boxwala, A., Greenes, R.: Enhancing arden syntax for clinical trial eligibility criteria. In: Proceedings AMIA Symposium (1999)"},{"key":"11_CR14","doi-asserted-by":"crossref","unstructured":"Weng, C., Tu, S.W., Sim, I., Richesson, R.: Formal representations of eligibility criteria: A literature review. Journal of Biomedical Informatics (2009)","DOI":"10.1016\/j.jbi.2009.12.004"}],"container-title":["Lecture Notes in Computer Science","Knowledge Representation for Health-Care"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-27697-2_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T23:03:11Z","timestamp":1556406191000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-27697-2_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9783642276965","9783642276972"],"references-count":14,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-27697-2_11","relation":{},"ISSN":["0302-9743","1611-3349"],"issn-type":[{"type":"print","value":"0302-9743"},{"type":"electronic","value":"1611-3349"}],"subject":[],"published":{"date-parts":[[2012]]}}}